Bourgeois Raphaëlle, Devillers Romain, Perrot Nicolas, Després Audrey-Anne, Boulanger Marie-Chloé, Mitchell Patricia L, Guertin Jakie, Couture Patrick, Boffa Michael B, Scipione Corey A, Pibarot Philippe, Koschinsky Marlys L, Mathieu Patrick, Arsenault Benoit J
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Québec, Canada.
JACC Basic Transl Sci. 2020 Aug 26;5(9):888-897. doi: 10.1016/j.jacbts.2020.06.012. eCollection 2020 Sep.
Our objectives were to determine whether autotaxin (ATX) is transported by lipoprotein(a) [Lp(a)] in human plasma and if could be used as a biomarker of calcific aortic valve stenosis (CAVS). We first found that ATX activity was higher in Lp(a) compared to low-density lipoprotein fractions in isolated fractions of 10 healthy participants. We developed a specific assay to measure ATX-Lp(a) in 88 patients with CAVS and 144 controls without CAVS. In a multivariable model corrected for CAVS risk factors, ATX-Lp(a) was associated with CAVS (p = 0.003). We concluded that ATX is preferentially transported by Lp(a) and might represent a novel biomarker for CAVS.
我们的目标是确定自分泌运动因子(ATX)是否在人血浆中由脂蛋白(a)[Lp(a)]转运,以及它是否可作为钙化性主动脉瓣狭窄(CAVS)的生物标志物。我们首先发现,在10名健康参与者的分离组分中,与低密度脂蛋白组分相比,Lp(a)中的ATX活性更高。我们开发了一种特异性检测方法,以测量88例CAVS患者和144例无CAVS的对照者中的ATX-Lp(a)。在针对CAVS危险因素校正的多变量模型中,ATX-Lp(a)与CAVS相关(p = 0.003)。我们得出结论,ATX优先由Lp(a)转运,可能代表CAVS的一种新型生物标志物。